Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details)

v3.21.1
Organization and Nature of Business (Details)
 3 Months Ended
Dec. 21, 2020
USD ($)
shares
Dec. 16, 2020
item
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Subsidiary, Sale of Stock [Line Items]          
Warrants to purchase shares | shares   172,500 172,500    
Warrants exercise price | $ / shares   $ 12.50 $ 12.50    
Warrants exercise price percenatge of IPO Price   125.00%      
Net loss     $ 3,056,033 $ 466,553  
Net cash used in operating activities     5,112,202 $ 277,379  
Accumulated deficit     $ 31,021,138   $ 27,965,105
IPO          
Subsidiary, Sale of Stock [Line Items]          
Shares issued | shares 3,450,000 3,000,000      
Share price | $ / shares   $ 10.00      
Gross proceeds $ 34,500,000        
Net proceeds $ 31,100,000        
Underwriter option          
Subsidiary, Sale of Stock [Line Items]          
Shares issued | shares   450,000      
Days to purchase additional shares granted to underwriters | item   45